Our Mission

To become a world leader in the development of targeted therapies for NASH and viral diseases to address important unmet medical needs.

Pipeline

Drawing upon our extensive experience in developing therapeutics for chronic liver diseases and viral infections, we are building a pipeline of potentially best-in-class drug candidates. These drug candidates target multiple clinically validated mechanisms of action and are designed to become transformative treatment options NASH and viral diseases.

Management Team

Our management team brings together years of experience and expertise with the goal of making Aligos a world leader in developing targeted therapies for hepatologic diseases and viral infections that affect millions of people around the world.

Our Mission

To become a world leader in the development of targeted therapies for NASH and viral diseases to address important unmet medical needs.

Meet the Aligos TeamAligos has brought together a group of remarkable individuals with years of experience and expertise.

Meet the Aligos Team

Aligos has brought together a group of remarkable individuals with years of experience and expertise.

Scientific Overview

We are engaged in the discovery and development of purpose-built, potentially best-in-class small molecule and oligonucleotide drug candidates that target clinically validated mechanisms of action in NASH and viral diseases